Michael Sabranski

Hamburg, HH 20146, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Comparable treatment response rates with benzathine penicillin and doxycycline in early syphilis: evidence from a large German cohort.

Comparable treatment response rates with benzathine penicillin and doxycycline in early syphilis: evidence from a large German cohort.

Journal: Infection

Published: June 10, 2026

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany.

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany.

Journal: Infection

Published: September 14, 2025

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies.

Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies.

Journal: Infectious diseases and therapy

Published: July 22, 2025

Effectiveness of switching to doravirine-based antiretroviral therapy: A real-world study in Germany.

Effectiveness of switching to doravirine-based antiretroviral therapy: A real-world study in Germany.

Journal: HIV medicine

Published: November 04, 2024

German evidence- and consensus-based guideline on the management of penile urethritis.

German evidence- and consensus-based guideline on the management of penile urethritis.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: October 07, 2024

Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemic.

Recently acquired HCV infection in men who have sex with men in Germany in the direct-acting antivirals era and during the COVID-19 pandemic.

Journal: HIV medicine

Published: December 14, 2023

Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice.

Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice.

Journal: Antiviral therapy

Published: March 06, 2020

Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy.

Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy.

Journal: AIDS care

Published: February 29, 2020

Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.

Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.

Journal: HIV medicine

Published: August 30, 2017

HIV-Associated Kaposi's Sarcoma.

HIV-Associated Kaposi's Sarcoma.

Journal: Oncology research and treatment

Published: November 03, 2016

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.

Journal: HIV medicine

Published: September 06, 2016

Intermittent viraemia and immune reconstitution in patients with more than 10-15 years of antiretroviral therapy: baseline values still matter.

Intermittent viraemia and immune reconstitution in patients with more than 10-15 years of antiretroviral therapy: baseline values still matter.

Journal: Journal of the International AIDS Society

Published: November 15, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026